Trademark: 86220538
Word
MEDFX
Status
Registered
Status Code
702
Status Date
Thursday, December 30, 2021
Serial Number
86220538
Registration Number
4842066
Registration Date
Tuesday, October 27, 2015
Mark Type
4000
Filing Date
Thursday, March 13, 2014
Published for Opposition
Tuesday, July 22, 2014

Trademark Owner History
Boston Research & Development, LLC - Original Registrant

Classifications
5 Pharmaceutical and dietary preparations for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases and metabolic disorders derived from plant extracts for therapeutical purposes
MED FX

Trademark Events
Dec 30, 2021
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Dec 30, 2021
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Dec 29, 2021
Case Assigned To Post Registration Paralegal
Sep 27, 2021
Teas Section 8 & 15 Received
Oct 27, 2020
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Oct 27, 2015
Registered-Principal Register
Sep 24, 2015
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 23, 2015
Allowed Principal Register - Sou Accepted
Sep 21, 2015
Statement Of Use Processing Complete
Sep 9, 2015
Use Amendment Filed
Sep 17, 2015
Case Assigned To Intent To Use Paralegal
Sep 9, 2015
Teas Statement Of Use Received
Mar 14, 2015
Notice Of Approval Of Extension Request E-Mailed
Mar 12, 2015
Extension 1 Granted
Mar 12, 2015
Extension 1 Filed
Mar 12, 2015
Teas Extension Received
Sep 16, 2014
Noa E-Mailed - Sou Required From Applicant
Jul 22, 2014
Official Gazette Publication Confirmation E-Mailed
Jul 22, 2014
Published For Opposition
Jul 2, 2014
Notification Of Notice Of Publication E-Mailed
Jun 18, 2014
Approved For Pub - Principal Register
Jun 17, 2014
Assigned To Examiner
Mar 28, 2014
Notice Of Pseudo Mark E-Mailed
Mar 27, 2014
New Application Office Supplied Data Entered In Tram
Mar 17, 2014
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24